XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2023   117,504        
Beginning Balance at Dec. 31, 2023 $ 346,344 $ 1,175 $ 1,185,100 $ (14,934) $ 38 $ (825,035)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]            
Exercise of stock options (in shares)   756        
Exercise of stock options 4,798 $ 7 4,791      
Vesting of restricted stock units (in shares)   2,497        
Vesting of restricted stock units 0 $ 25 (25)      
Vesting of performance stock units (in shares)   88        
Vesting of performance stock units 0 $ 1 (1)      
Issuance of common stock under employee stock purchase plan (in shares)   499        
Issuance of common stock under employee stock purchase plan 16,262 $ 5 16,257      
Purchase of treasury stock (49,991)     (49,991)    
Fair value of replacement equity attributable to pre-acquisition service 42   42      
Stock-based compensation 124,353   124,353      
Other comprehensive income (loss) 916       916  
Net income (loss) (38,169)         (38,169)
Ending balance (in shares) at Sep. 30, 2024   121,344        
Ending Balance at Sep. 30, 2024 404,555 $ 1,213 1,330,517 (64,925) 954 (863,204)
Beginning Balance (in shares) at Jun. 30, 2024   120,461        
Beginning Balance at Jun. 30, 2024 363,561 $ 1,205 1,281,545 (64,925) (271) (853,993)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]            
Exercise of stock options (in shares)   109        
Exercise of stock options 663 $ 1 662      
Vesting of restricted stock units (in shares)   561        
Vesting of restricted stock units 0 $ 5 (5)      
Vesting of performance stock units (in shares)   19        
Issuance of common stock under employee stock purchase plan (in shares)   194        
Issuance of common stock under employee stock purchase plan 6,384 $ 2 6,382      
Stock-based compensation 41,933   41,933      
Other comprehensive income (loss) 1,225       1,225  
Net income (loss) (9,211)         (9,211)
Ending balance (in shares) at Sep. 30, 2024   121,344        
Ending Balance at Sep. 30, 2024 $ 404,555 $ 1,213 1,330,517 (64,925) 954 (863,204)
Beginning Balance (in shares) at Dec. 31, 2024 122,371 122,371        
Beginning Balance at Dec. 31, 2024 $ 399,954 $ 1,224 1,374,659 (114,911) 318 (861,336)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]            
Exercise of stock options (in shares) 2,519 2,034        
Exercise of stock options $ 2,420 $ 20 2,400      
Vesting of restricted stock units (in shares)   3,089        
Vesting of restricted stock units 0 $ 31 (31)      
Vesting of performance stock units (in shares)   198        
Vesting of performance stock units 0 $ 2 (2)      
Issuance of restricted stock awards, net (in shares)   137        
Forfeiture of restricted stock awards 0 $ 1 (1)      
Issuance of common stock under employee stock purchase plan (in shares)   519        
Issuance of common stock under employee stock purchase plan 15,482 $ 5 15,477      
Taxes paid related to net share settlement of equity awards (1,329)     (1,329)    
Purchase of treasury stock (184,968)     (184,968)    
Fair value of replacement equity attributable to pre-acquisition service 146   146      
Stock-based compensation 147,963   147,963      
Other comprehensive income (loss) 89       89  
Net income (loss) $ (35,381)         (35,381)
Ending balance (in shares) at Sep. 30, 2025 128,348 128,348        
Ending Balance at Sep. 30, 2025 $ 344,376 $ 1,283 1,540,611 (301,208) 407 (896,717)
Beginning Balance (in shares) at Jun. 30, 2025   127,352        
Beginning Balance at Jun. 30, 2025 350,699 $ 1,274 1,489,379 (241,239) 262 (898,977)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]            
Exercise of stock options (in shares)   17        
Exercise of stock options 233 $ 0 233      
Vesting of restricted stock units (in shares)   792        
Vesting of restricted stock units 0 $ 8 (8)      
Vesting of performance stock units (in shares)   17        
Issuance of restricted stock awards, net (in shares)   (50)        
Forfeiture of restricted stock awards 0 $ (1) 1      
Issuance of common stock under employee stock purchase plan (in shares)   220        
Issuance of common stock under employee stock purchase plan 5,770 $ 2 5,768      
Purchase of treasury stock (59,969)     (59,969)    
Stock-based compensation 45,238   45,238      
Other comprehensive income (loss) 145       145  
Net income (loss) $ 2,260         2,260
Ending balance (in shares) at Sep. 30, 2025 128,348 128,348        
Ending Balance at Sep. 30, 2025 $ 344,376 $ 1,283 $ 1,540,611 $ (301,208) $ 407 $ (896,717)